Greenleaf Trust’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-14,141
Closed -$219K 790
2023
Q3
$219K Buy
14,141
+2,168
+18% +$33.6K ﹤0.01% 685
2023
Q2
$188K Buy
11,973
+339
+3% +$5.55K ﹤0.01% 731
2023
Q1
$192K Buy
+11,634
New +$185K ﹤0.01% 740
2022
Q4
Sell
-22,884
Closed -$297K 769
2022
Q3
$297K Sell
22,884
-6,034
-21% -$83.9K ﹤0.01% 538
2022
Q2
$406K Sell
28,918
-16,168
-36% -$231K 0.01% 465
2022
Q1
$646K Buy
45,086
+14,484
+47% +$213K 0.01% 345
2021
Q4
$417K Buy
30,602
+7,674
+33% +$108K ﹤0.01% 483
2021
Q3
$376K Buy
22,928
+5,796
+34% +$97.3K ﹤0.01% 500
2021
Q2
$288K Sell
17,132
-7,564
-31% -$129K ﹤0.01% 590
2021
Q1
$451K Buy
+24,696
New +$444K 0.01% 409
2020
Q4
Sell
-19,502
Closed -$348K 637
2020
Q3
$348K Buy
19,502
+5,324
+38% +$96.9K 0.01% 374
2020
Q2
$254K Buy
+14,178
New +$255K ﹤0.01% 441
2020
Q1
Sell
-19,386
Closed -$382K 589
2019
Q4
$382K Sell
19,386
-3,302
-15% -$63.2K 0.01% 353
2019
Q3
$390K Buy
+22,688
New +$392K 0.01% 340
2019
Q2
Sell
-16,254
Closed -$331K 562
2019
Q1
$331K Buy
+16,254
New +$327K 0.01% 364

Other funds holding TAK